Insider filing · TMCI
Sean F. Scanlan
Chief Innovation Officer
profile →
Treace Medical Concepts, Inc.
TMCI · Healthcare · 7 filings in 24 months
ticker →
Sean F. Scanlan sold $398K of Treace Medical Concepts (TMCI)
Executed Mar 17 2025, disclosed Mar 19 2025, 2 days later.
Value, as filed
$398K
50,000 sh × $7.97
Executed
Mar 17 2025
the trade date, as filed
Disclosed
Mar 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSSean F. Scanlan (Chief Innovation Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Treace Medical Concepts, Inc. (TMCI). The largest single filing was $398K of TMCI (50,000 sh × $7.97, as filed), executed Mar 17 2025.
The name
TMCIHealthcare · Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→